Gyrate Atrophy is a rare eye condition. It causes the back layers of the eye to slowly thin out over time, starting in childhood. This can affect vision and may need treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Low-Protein Diet for Gyrate Atrophy?
Gyrate atrophy (in full, gyrate atrophy of the choroid and retina) is a rare inherited condition in which the light-sensing tissue at the back of the eye, the retina, and the layer of blood vessels beneath it, the choroid, gradually wear away. It affects both eyes and causes vision loss that worsens over many years. Symptoms usually start in childhood. Nearsightedness, often strong, and trouble seeing in dim light are typically the first signs. Vision at the edges is lost next, so the field of view slowly narrows toward tunnel vision. Central vision, used for reading and recognizing faces, often lasts for decades but can eventually be affected too. Cataracts (clouding of the lens) commonly develop early, and many people become legally or functionally blind in adulthood. The underlying problem is chemical, not structural: the body cannot properly break down ornithine, an amino acid, so it builds up in the blood and in the eye. Most people's symptoms are limited to their eyes, but some have mild muscle weakness, numbness or tingling in the hands and feet, or seizures. Rarely, a newborn first shows the condition through a rise in blood ammonia that causes poor feeding or vomiting; this usually responds quickly to treatment and does not return.
Gyrate atrophy is caused by changes in the gene for ornithine aminotransferase (OAT), an enzyme that normally breaks ornithine down. When the enzyme does not work, ornithine in the blood rises well above normal. Researchers think the excess ornithine damages retinal cells, and that it also reduces the body's production of creatine, a molecule muscles and nerves use for energy, which may explain the muscle and nerve symptoms some people have. The condition is inherited in an autosomal recessive pattern. A person has it only when both copies of the gene, one from each parent, are altered. Parents who each carry one altered copy usually have no symptoms, and each of their children has a one in four chance of being affected. Nothing a person or parent did causes gyrate atrophy, and it is not brought on by infections or other outside exposures. It is very rare worldwide but more common in Finland, where an inherited founder variant is more frequent.
An eye specialist often suspects gyrate atrophy from a dilated eye exam. The back of the eye shows round, sharply edged patches of thinned tissue near the periphery that spread and merge over time, a pattern quite distinctive for this disease. Imaging of the retina and tests of the side vision and of how the retina responds to light help measure how far the changes have progressed. The diagnosis is confirmed with a blood test of amino acids that shows a high level of ornithine. Genetic testing, often as part of a panel for inherited retinal diseases, can identify the changes in both copies of the gene. Because the condition runs in families, brothers and sisters of an affected person are often tested too, sometimes before symptoms begin. Some centers also test whether a person's ornithine falls in response to vitamin B6, since that changes treatment.
There is currently no cure and no international treatment guideline, so care varies between centers and is usually led by a metabolic specialist and an eye specialist together. Treatment aims to lower ornithine, on the reasoning that less ornithine means less damage to the retina. The evidence for this comes from small studies rather than large trials, but long-term reduction of ornithine appears to slow retinal damage, and children who start treatment earlier seem to keep more of their side vision. The main approach is a diet low in protein, especially arginine, an amino acid the body turns into ornithine. Because such a diet cuts out much ordinary protein, it is supplemented with special amino acid formulas to meet nutritional needs, and it should be planned and monitored with a metabolic dietitian. It is demanding to follow for years, and even with strict adherence ornithine often does not return fully to normal. A minority of people respond to high-dose vitamin B6 (pyridoxine), which helps the faulty enzyme work and lowers ornithine. A supervised trial with repeat blood tests shows whether it helps. Creatine supplements are often given to replace what the body makes too little of, though their effect on symptoms is uncertain, and lysine, another amino acid, has been tried in small studies to increase the amount of ornithine lost in the urine. Eye complications are treated as they arise. Cataract surgery is often needed by the late twenties. Swelling in the center of the retina (cystoid macular edema) is commonly treated with acetazolamide pills or similar eye drops that reduce fluid, with variable results.
Gyrate atrophy progresses slowly but steadily, and the pace differs from person to person, even within the same family. Night vision and side vision usually decline first, which affects moving around in the dark, crowded places and, eventually, eligibility to drive. Many people keep useful central vision for reading into adulthood, though cataracts or swelling in the retina can blur it sooner and often improve with treatment. Treatment may slow the disease, but it does not reliably prevent serious vision loss. Living with the condition usually means regular blood tests to track ornithine, check-ins with a dietitian, and eye exams to follow vision and catch treatable complications. Low-vision rehabilitation, which teaches skills and provides tools such as magnifiers, lighting and mobility training, helps people stay independent and is worth starting early rather than waiting for severe loss. Genetic counseling helps families understand the chances for siblings and future children. Gene and other experimental therapies are being studied, but none is available yet.
See an eye specialist if a child or adult has strong nearsightedness together with poor night vision or narrowing side vision, or if a relative has gyrate atrophy, since early diagnosis allows earlier treatment. If you already have the diagnosis, keep regular appointments and contact your care team if vision seems to be getting worse faster than before, or if the diet or supplements are hard to keep up. Call your eye care professional right away for a sudden change in vision, new flashes of light, a curtain or shadow over part of your view, or eye pain, which can signal a complication such as retinal detachment that needs prompt treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Gyrate Atrophy is like, what's helped you, or ask the community a question.